Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -695.44% is 85% above its 5-year average of -4572.94%, near the high end of its 5-year range (-52277.91%–-12.22%).
69.19% above its 12-month average of -2256.95%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -551.11%.
OPERATING MARGIN
-695.44%
OPERATING MARGIN AVG TTM
-2256.95%
OPERATING MARGIN AVG 3Y
-10127.84%
OPERATING MARGIN AVG 5Y
-4572.94%
OPERATING MARGIN AVG 10Y
-1734.34%
OPERATING MARGIN AVG 15Y
-550.38%
OPERATING MARGIN AVG 20Y
-654.30%
CURRENT VS TTM AVG
+69.19%
CURRENT VS 3Y AVG
+93.13%
CURRENT VS 5Y AVG
+84.79%
CURRENT VS 10Y AVG
+59.90%
CURRENT VS 15Y AVG
-26.36%
CURRENT VS 20Y AVG
-6.29%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 496 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Cytokinetics, Incorporated
Market Cap
$7.80B
Operating Margin
-695.44%
TTM Avg
-2256.95%
3Y Avg
-10127.84%
5Y Avg
-4572.94%
Market Cap
$7.65B
Operating Margin
25.61%
TTM Avg
21.87%
3Y Avg
15.23%
5Y Avg
12.87%
Market Cap
$7.61B
Operating Margin
-92.94%
TTM Avg
-50.55%
3Y Avg
-48.57%
5Y Avg
-48.57%
Market Cap
$7.23B
Operating Margin
-40.47%
TTM Avg
-53.92%
3Y Avg
-55.65%
5Y Avg
-41.65%
Market Cap
$8.41B
Operating Margin
4.07%
TTM Avg
-1.39%
3Y Avg
-5.39%
5Y Avg
-20.02%
Market Cap
$8.59B
Operating Margin
5.56%
TTM Avg
-28.40%
3Y Avg
-70.84%
5Y Avg
-47.21%
Market Cap
$8.78B
Operating Margin
11.86%
TTM Avg
-8457.60%
3Y Avg
-4268.44%
5Y Avg
-2881.23%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cytokinetics, Incorporated (CYTK) | $7.80B | -695.44% | -2256.95% | -10127.84% | -4572.94% |
| HealthEquity, Inc. (HQY)vs › | $7.65B | 25.61% | 21.87% | 15.23% | 12.87% |
| Hinge Health, Inc. (HNGE)vs › | $7.61B | -92.94% | -50.55% | -48.57% | -48.57% |
| Ionis Pharmaceuticals, Inc. (IONS)vs › | $7.23B | -40.47% | -53.92% | -55.65% | -41.65% |
| Oscar Health, Inc. (OSCR)vs › | $8.41B | 4.07% | -1.39% | -5.39% | -20.02% |
| Alkermes plc (ALKS)vs › | $7.17B | 17.21% | 22.11% | 17.14% | 11.01% |
| Caris Life Sciences, Inc. (CAI)vs › | $8.59B | 5.56% | -28.40% | -70.84% | -47.21% |
| Immunovant, Inc. (IMVT)vs › | $6.86B | 0.00% | 0.00% | 0.00% | 0.00% |
| Arrowhead Pharmaceuticals, Inc. (ARWR)vs › | $8.78B | 11.86% | -8457.60% | -4268.44% | -2881.23% |
| Chemed Corporation (CHE)vs › | $6.68B | 13.46% | 14.22% | 14.89% | 15.72% |
Gross Margin
85.0%
Operating Margin
-695.4%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -551.11% |
| 2026-03-31 | -948.69% |
| 2025-12-31 | -1004.60% |
| 2025-09-30 | -8613.38% |
| 2025-06-30 | -167.00% |
| 2025-03-31 | -9856.30% |
| 2024-12-31 | -821.41% |
| 2024-09-30 | -30410.58% |
| 2024-06-30 | -52277.91% |
| 2024-03-31 | -15117.96% |
| 2023-12-31 | -7620.69% |
| 2023-09-30 | -32345.24% |
| 2023-06-30 | -14077.16% |
| 2023-03-31 | -2698.31% |
| 2022-12-31 | -6491.06% |
| 2022-09-30 | -4311.77% |
| 2022-06-30 | -12.22% |
| 2022-03-31 | -6781.97% |
| 2021-12-31 | -39.04% |
| 2021-09-30 | -1272.78% |
| 2021-06-30 | -1927.44% |
| 2021-03-31 | -620.20% |
| 2020-12-31 | -541.61% |
| 2020-09-30 | 12.44% |
| 2020-06-30 | -900.58% |
| 2020-03-31 | -793.78% |
| 2019-12-31 | -454.83% |
| 2019-09-30 | -395.16% |
| 2019-06-30 | -374.33% |
| 2019-03-31 | -289.67% |
| 2018-12-31 | -228.85% |
| 2018-09-30 | -168.35% |
| 2018-06-30 | -376.72% |
| 2018-03-31 | -496.03% |
| 2017-12-31 | 202927.78% |
| 2017-09-30 | -459.94% |
| 2017-06-30 | -825.22% |
| 2017-03-31 | -559.86% |
| 2016-12-31 | 23.20% |
| 2016-09-30 | 55.02% |
| 2016-06-30 | -189.78% |
| 2016-03-31 | -141.95% |
| 2015-12-31 | -92.46% |
| 2015-09-30 | -111.87% |
| 2015-06-30 | -161.86% |
| 2015-03-31 | -201.84% |
| 2014-12-31 | 38.70% |
| 2014-09-30 | -63.71% |
| 2014-06-30 | -107.95% |
| 2014-03-31 | -109.91% |
| 2013-12-31 | 26.42% |
| 2013-09-30 | -282.19% |
| 2013-06-30 | -1493.36% |
| 2013-03-31 | -1540.44% |
| 2012-12-31 | -463.97% |
| 2012-09-30 | -587.69% |
| 2012-06-30 | -486.47% |
| 2012-03-31 | -546.15% |
| 2011-12-31 | -1571.60% |
| 2011-09-30 | -747.58% |
| 2011-06-30 | -1296.01% |
| 2011-03-31 | -1540.24% |
| 2010-12-31 | -1058.42% |
| 2010-09-30 | -3189.09% |
| 2010-06-30 | -2847.19% |
| 2010-03-31 | -1977.94% |
| 2009-12-31 | -1212.12% |
| 2009-09-30 | -149.07% |
| 2009-06-30 | 80.00% |
| 2009-03-31 | -352.27% |
| 2008-12-31 | -353.43% |
| 2008-09-30 | -534.78% |
| 2008-06-30 | -521.70% |
| 2008-03-31 | -494.95% |
| 2007-12-31 | -480.96% |
| 2007-09-30 | -319.61% |
| 2007-06-30 | -458.42% |
| 2007-03-31 | -429.45% |
| 2006-12-31 | -10954.84% |
| 2006-09-30 | -15095.28% |
| 2006-06-30 | -1029.67% |
| 2006-03-31 | -948.45% |
| 2005-12-31 | -545.52% |
| 2005-09-30 | -578.38% |
| 2005-06-30 | -474.20% |
| 2005-03-31 | -431.88% |
| 2004-12-31 | -552.11% |
| 2004-09-30 | -435.08% |
| 2004-06-30 | -328.31% |
| 2004-03-31 | -101.72% |
| 2003-12-31 | -1532.64% |
| 2003-09-30 | 100.00% |
| 2003-06-30 | -304.31% |
| 2003-03-31 | -259.37% |
